ID

26223

Descripción

Study ID: 101468/125 Clinical Study ID: SKF-101468/125 Study Title: A double-blind, multicentre, flexible dose, L-dopa controlled study of ropinirole to investigate A) neuroprotective effect as measured by 3D PET scanning, and B) ophthalmological safety, in patients with early Parkinson’s disease Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: requip Study Indication: Restless Legs Syndrome

Palabras clave

Versiones (1)
  1. 12/10/17 12/10/17 -
Titular de derechos de autor

GlaxoSmithKline

Subido en

12 de octubre de 2017

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

L-dopa controlled study of ropinirole, neuroprotective effect and ophthalmological safety in early Parkinson’s disease 101468/125 Module 1 Visit 3 Week 2 (optional visit)

Inglés

L-dopa controlled study of ropinirole, neuroprotective effect and ophthalmological safety in early Parkinson’s disease 101468/125 Module 1 Visit 3 Week 2 (optional visit)

1 formularios  
Vital signs
Descripción

Vital signs

Sitting blood pressure (systolic)
Descripción

Sitting blood pressure (systolic)

Tipo de datos

integer

Unidades de medida
  • mmHg
mmHg
Sitting blood pressure (diastolic)
Descripción

Sitting blood pressure (diastolic)

Tipo de datos

integer

Unidades de medida
  • mmHg
mmHg
Sitting Heart Rate
Descripción

Sitting Heart Rate

Tipo de datos

integer

Unidades de medida
  • beats/min
beats/min
Concomitant medication
Descripción

Concomitant medication

Concomitant medication
Descripción

Record any change in the patient´s concomitant medication since the last visit in the Concomitant Medication section towards the back of this module.

Tipo de datos

text

Adverse Experiences
Descripción

Adverse Experiences

Adverse Experiences
Descripción

Have there been any adverse experiences observed or elicited by the following direct question to the patient: "Have you felt different in any way since your last visit"? Transcribe any ongoing Baseline Adverse Experiences recorded on page 10, record any changes to ongoing Baseline Adverse Experiences section towards the back of this module.

Tipo de datos

text

Study Medication Compliance
Descripción

Study Medication Compliance

Record the date on which the patient started to take study medication in the space provided at the top of page 18. Has the patient been compliant with study medication? (Compliance is defined as taking between approximately 80%-120% of medication)
Descripción

Study Medication Compliance

Tipo de datos

boolean

Patient continuation
Descripción

Patient continuation

Remind the patient of the date and time of their next visit.
Descripción

Patients continuing

Tipo de datos

boolean

Complete the Patient Continuation/Withdrawal section at the back of this module.
Descripción

Patients withdrawing

Tipo de datos

boolean

Volver a la parte superior de la página

Similar models

L-dopa controlled study of ropinirole, neuroprotective effect and ophthalmological safety in early Parkinson’s disease 101468/125 Module 1 Visit 3 Week 2 (optional visit)

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
Vital signs
Sitting blood pressure (systolic)
Item
Sitting blood pressure (systolic)
integer
Sitting blood pressure (diastolic)
Item
Sitting blood pressure (diastolic)
integer
Sitting Heart Rate
Item
Sitting Heart Rate
integer
Item Group
Concomitant medication
Concomitant medication
Item
Concomitant medication
text
Item Group
Adverse Experiences
Adverse Experiences
Item
text
Item Group
Study Medication Compliance
Study Medication Compliance
Item
Record the date on which the patient started to take study medication in the space provided at the top of page 18. Has the patient been compliant with study medication? (Compliance is defined as taking between approximately 80%-120% of medication)
boolean
Item Group
Patient continuation
Patients continuing
Item
Remind the patient of the date and time of their next visit.
boolean
Patients withdrawing
Item
Complete the Patient Continuation/Withdrawal section at the back of this module.
boolean
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial